Nasdaq biol.

LAKE FOREST, Calif., June 21, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced today the extension of its digital learning webinar series ...

Nasdaq biol. Things To Know About Nasdaq biol.

BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...Jun 5, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of ... (NASDAQ: BIOL), the global leader in dental lasers, announced today that due to the growing adoption of its market leading laser technology, BIOLASE has taken the innovative step of creating a ...Graphite Bio, Inc. (Nasdaq – GRPH) Under the terms of the agreement, Graphite Bio will merge with LENZ Therapeutics in an all-stock transaction. Under the …

LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously ...4 Oct 2012 ... Nasdaq: BIOL. PAGE 1. Exhibit 99.1. The BIOLASE. Total Solution. The ... Eliminates accidental sticks with contaminated burs. BIOLASE'S Waterlase ...

BIOLASE, Inc. (NASDAQ:BIOL) posted its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share for the quarter, topping analysts' consensus estimates of ($75.00) by $25.00. The medical technology company had revenue of $9.53 million for the quarter.

BIOL’s shares have dropped by -21.84% in the last five days, while they have subtracted -8.67% in the last month. Further, it is currently trading at a price-to-book ratio of 1.12. LORD JONATHAN T MD, Director, of BIOLASE Inc. (BIOL), sold 11,038 BIOLASE Inc. stock in an exchange on Dec 15.BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units ...Nov 14, 2022 · LAKE FOREST, Calif., Nov. 14, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11 th Annual ... BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -...

FOOTHILL RANCH, Calif., March 23, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that President and CEO, John Beaver, has been invited to ...

May 26, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units ...

The 36-month beta value for BIOL is also noteworthy at 1.33. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”. The average price estimated by analysts for BIOL is $16.33, which is $14.66 above than the current price.BIOLASE (NASDAQ:BIOL – Get Free Report) last posted its earnings results on Thursday, August 10th. The medical technology company reported ($8.93) earnings per share (EPS) for the quarter.LAKE FOREST, Calif., Nov. 14, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11 th Annual ...Dental technology company Sonendo ( NYSE: SONX) on Wednesday said its unit PIPStek had filed a patent infringement lawsuit against maker of dental lasers Biolase ( NASDAQ: BIOL ). The lawsuit was ...Dec 1, 2023 · BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. LAKE FOREST, Calif. , Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public ... Feb 10, 2022 · The image below, which you can click on for greater detail, shows that BIOLASE had debt of US$13.5m at the end of September 2021, a reduction from US$16.1m over a year. But it also has US$33.4m in ... BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group. This award is in addition ...

LAKE FOREST, Calif., June 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a ...LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared ...NASDAQNYSEIBEX35LSEDAXCRYPTO. Buscar. NASDAQ:BIOL. BIOLASE Inc. Sector. Health. Industry. Medical supplies and equipment. 1,65 $ Last price. -0,03 $ VARIATION.Biolase, Inc. (Nasdaq: BIOL) is a global leader in dental lasers. In August 2022 , Biolase reported second quarter 2022 financial results, including total revenue of $12.2 million , a 34% year ...LAKE FOREST, Calif., Feb. 21, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has further advanced its market awareness and ...LAKE FOREST, Calif., June 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a ...

Feb 4, 2021 · According to the recent notification letter, the staff of NASDAQ has determined that for the last ten consecutive business days, from January 21, 2021 to February 3, 2021, the closing bid price of ... Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies Stocks

The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.(NASDAQ: BIOL), the global leader in dental lasers, announced today the U.S. launch of the Waterlase Fractional Handpiece for doctors seeking a faster and more efficient way to perform skin ...Biolase (BIOL) stock is flying high on Tuesday after announcing a massive deal for its dental lasers with Dental Care Alliance. BIOLASE down 30%, prices $4.5M stock offering (NASDAQ:BIOL) From ...May 26, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units ... Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.BIOL U.S.: Nasdaq Biolase Inc. Watch list NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:47 p.m. EST Delayed quote $ 1.1600 0.01 0.87% After Hours Volume: 175 Advanced... LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that President and Chief Executive Officer, John Beaver and Chief Financial Officer, Jennifer Bright, have been invited to participate in the 2023 Virtual Healthcare Conference, presented by Maxim …You can click the graphic below for the historical numbers, but it shows that BIOLASE had US$13.1m of debt in June 2021, down from US$16.7m, one year before. However, its balance sheet shows it ...BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...Posted by Techdows on Nov 30th, 2023. StockNews.com lowered shares of BIOLASE ( NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Separately, Benchmark cut their price objective on shares of BIOLASE from $10.00 to $4.00 in a research report on Wednesday, September 20th. Get BIOLASE alerts:

LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...

FOOTHILL RANCH, Calif., May 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today sent the following letter to stockholders regarding the upcoming 2021 ...

Biolase Inc (NASDAQ:BIOL) $1.165 -0.075 [-6.05%] Last update: 3:45PM (Delayed 15-Minutes) Get Real Time Here $1.17 0.0050 [0.43%] Profile News Analyst …LAKE FOREST, Calif., Feb. 21, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has further advanced its market awareness and ...May 24, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with ... Gainers Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares jumped 537.5% to close at $25.50 on Wednesday after the company priced its IPO at $4 per share.BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ... Feb 10, 2021 · FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ... LAKE FOREST, Calif., March 6, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced plans to launch a second season of the popular podcast series ...IRVINE, Calif., June 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with ...Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.

Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies StocksEarnings announcement* for BIOL: Nov 09, 2022. Biolase, Inc. is estimated to report earnings on 11/09/2022. The upcoming earnings date is derived from an algorithm based on a company's historical ...BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ...How are hedge funds trading Biolase Inc (NASDAQ:BIOL)? Heading into the fourth quarter of 2020, a total of 4 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 33 ...Instagram:https://instagram. day trading thinkorswimarista networks inc.flyjetsbest mortgage virginia 3 Oct 2023 ... Math. Biol. Neurosci. ISSN 2052-2541. Editorial Office: [email protected]. Copyright ©2023 CMBN.BIOLASE, Inc. (NASDAQ:BIOL) posted its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share for the quarter, topping analysts' consensus estimates of ($75.00) by $25.00. The medical technology company had revenue of $9.53 million for the quarter. are liberty dimes worth anythinghow to sell shares As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq. harley stocks BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ...